Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 121.25M P/E - EPS this Y 52.00% Ern Qtrly Grth -
Income -104.77M Forward P/E -1.16 EPS next Y 1.40% 50D Avg Chg -78.00%
Sales 29.94M PEG - EPS past 5Y - 200D Avg Chg -81.00%
Dividend N/A Price/Book 1.80 EPS next 5Y - 52W High Chg -89.00%
Recommedations 1.70 Quick Ratio 2.64 Shares Outstanding 122.68M 52W Low Chg 32.00%
Insider Own 1.20% ROA -26.30% Shares Float 72.18M Beta 1.47
Inst Own 94.24% ROE -213.33% Shares Shorted/Prior 10.31M/8.49M Price 1.06
Gross Margin -193.81% Profit Margin - Avg. Volume 7,580,212 Target Price 6.50
Oper. Margin -1,110.12% Earnings Date Nov 5 Volume 4,872,353 Change -9.40%
About Mersana Therapeutics, Inc.

Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet needs. The company develops XMT-1660, a B7-H4-targeted Dolasynthen ADC candidate; and XMT-2056, an immunosynthen ADC. It has research and development collaborations with Janssen Biotech, Inc., Ares Trading S.A., Merck KGaA, and Asana BioSciences, LLC for the development of ADC product candidates. The company was formerly known as Nanopharma Corp. and changed its name to Mersana Therapeutics, Inc. in November 2005. Mersana Therapeutics, Inc. was incorporated in 2001 and is headquartered in Cambridge, Massachusetts.

Mersana Therapeutics, Inc. News
11/14/24 Mersana Therapeutics Inc (MRSN) Q3 2024 Earnings Call Highlights: Strategic Advances and ...
11/14/24 Q3 2024 Mersana Therapeutics Inc Earnings Call
11/13/24 Mersana Therapeutics, Inc. (MRSN) Reports Q3 Loss, Tops Revenue Estimates
11/13/24 Mersana Therapeutics Provides Business Update and Announces Third Quarter 2024 Financial Results
11/06/24 Mersana Therapeutics to Host Third Quarter 2024 Conference Call on November 13, 2024
08/16/24 Mersana Therapeutics, Inc. (NASDAQ:MRSN) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
08/13/24 Mersana Therapeutics, Inc. (MRSN) Reports Q2 Loss, Misses Revenue Estimates
08/13/24 Mersana Therapeutics Provides Business Update and Announces Second Quarter 2024 Financial Results
08/06/24 Mersana Therapeutics to Host Second Quarter 2024 Conference Call on August 13, 2024
08/01/24 Mersana Therapeutics (NASDAQ:MRSN) shareholders have endured a 83% loss from investing in the stock three years ago
05/22/24 Mersana Therapeutics to Present at Upcoming Investor Conferences
05/10/24 Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q1 2024 Earnings Call Transcript
05/10/24 Mersana Therapeutics Inc (MRSN) Reports Q1 2024 Financial Results: A Detailed Analysis
05/09/24 Mersana Therapeutics, Inc. (MRSN) Reports Q1 Loss, Misses Revenue Estimates
05/09/24 Mersana Therapeutics Provides Business Update and Announces First Quarter 2024 Financial Results
05/03/24 Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05/02/24 Mersana Therapeutics to Host First Quarter 2024 Conference Call on May 9, 2024
04/05/24 Strength Seen in Curis (CRIS): Can Its 19.5% Jump Turn into More Strength?
02/29/24 Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q4 2023 Earnings Call Transcript
02/29/24 An Intrinsic Calculation For Mersana Therapeutics, Inc. (NASDAQ:MRSN) Suggests It's 26% Undervalued
MRSN Chatroom

User Image GoofyAhh Posted - 22 hours ago

$MRSN

User Image snugmunchkin Posted - 2 days ago

$MRSN Honestly, even if it fails Im not too worried about it right now. Earnings were good. Im sure it will recover.

User Image snugmunchkin Posted - 2 days ago

$MRSN We're right on a support level. If $2 fails, expect it to go to 1.84

User Image COStockMonkey81 Posted - 2 days ago

$MRSN what's going on here?

User Image _www_larval_com_ Posted - 3 days ago

$MRSN has popped 6% higher to 0% (~888Kv) a moment ago, 12/20 options, follow for more volatility.

User Image snugmunchkin Posted - 3 days ago

$MRSN $2 on deck. Sigh

User Image COStockMonkey81 Posted - 5 days ago

$MRSN 25% loss in 24 hrs. Not looking good at all.

User Image QuantInsider Posted - 1 week ago

I've been keeping an eye on $MRSN, and it looks like the options volume has really picked up—sitting at about 2.0x now. It’s intriguing to think this could mean some larger players are starting to get interested. Makes you wonder what they see that we might not. How do you all feel about the potential for this stock in the near term?

User Image snugmunchkin Posted - 1 week ago

$MRSN MIGHT fill the gap down before going back up, before presumably recovering.

User Image jParkz Posted - 1 week ago

$MRSN News Mersana Therapeutics Provides Business Update and Announces Third Quarter 2024 Financial Results https://marketwirenews.com/news-releases/mersana-therapeutics-provides-business-update-and-an-9005413050276733.html $MRSN

User Image pinbal Posted - 1 week ago

$MRSN how is this work. Other stocks are going green with high volume . Less earnings. This is positive and moving .10 cents??

User Image BobBuran Posted - 1 week ago

Wednesday This is the second of TWO posts showing a total of about 50 of my buy stop orders (LE for long entry) above the market for today. Already bot past ten minutes: $ENSC $MRSN $RDDT #stocks

User Image BobBuran Posted - 1 week ago

Wednesday This is the first of TWO posts showing a total of about 50 of my buy stop orders (LE for long entry) above the market for today. Already bot past ten minutes: $ENSC $MRSN $RDDT #stocks

User Image kiwitc2000 Posted - 1 week ago

$MRSN $DAVE $NTRA $HNST Going according to plan. $ICAD Disappointing so far, but the day is young.

User Image brendanscottsmith Posted - 1 week ago

$MRSN are the majority of humans bad people or good people?

User Image dln101 Posted - 1 week ago

$CYCC first stop $0.7.. if it goes crazy like in the past then $1.7 🎯 🤔💪🔥🚀 $KXIN $MRSN style

User Image brendanscottsmith Posted - 1 week ago

$MRSN load up for 3s

User Image briefingcom Posted - 1 week ago

$MRSN: Mersana Therapeutics beats by $0.08, beats on revs https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20241113070626MRSN&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page

User Image G101SPM Posted - 1 week ago

$MRSN $2.38 bid. DAC (dollar average cost) $1.37 (8.13.24). EXIT $8.00 long term. BRIEF: Reports Q3 (Sep) loss of $0.09 per share, $0.08 better than consensus of ($0.17); revenues rose 63.6% year/year to $12.6 mln vs the $7.53 mln. Cash, cash equivalents and marketable securities as of September 30, 2024, were $155.2 million. note: Mersana capital resources are sufficient to support its current operates into 2026.

User Image COStockMonkey81 Posted - 1 week ago

$MRSN why is this dumping?

User Image brendanscottsmith Posted - 1 week ago

$MRSN beautiful 🙏

User Image _www_larval_com_ Posted - 1 week ago

$MRSN just jumped 3% higher to 12% (~2Mv) a few minutes ago, 11/15 options, follow for more volatility.

User Image BobBuran Posted - 2 weeks ago

Thursday FIFTEEN MINUTES IN Dow -4 and we are carrying +$20,386 with $MRSN $NNE and $POWL #stocks

User Image PLATINUM_TRADES Posted - 2 weeks ago

$MRSN BOB never loses ever😵‍💫😵‍💫🤷🤷.... We are up nicely!! $2.75 major resistance

User Image BobBuran Posted - 2 weeks ago

Thursday Dow opens -25 and we open carrying +$6,474 with $MRSN and $POWL #stocks

User Image PLATINUM_TRADES Posted - 2 weeks ago

$MRSN $2.50 to break I told u this was gonna have money 👇 look🥇🥇

User Image PLATINUM_TRADES Posted - 2 weeks ago

$MRSN nice pop today we gonna keep it with $2.75 major resistance looks like more is on the way🥇🥇🏆🏆

User Image UnsettledOnPurpose Posted - 2 weeks ago

$MRSN Nope.

User Image DougieFreshPicks Posted - 2 weeks ago

$CETX $ASM $MRSN Just added them!!!

User Image BobBuran Posted - 2 weeks ago

Wednesday Dow closes a record + 1508 and we close carrying + $7,747 with $POWL and $MRSN #stocks

Analyst Ratings
Citigroup Buy Aug 27, 24
Baird Neutral Aug 14, 24
JP Morgan Neutral Mar 19, 24
Wedbush Outperform Feb 29, 24
Truist Securities Buy Feb 29, 24
Baird Neutral Feb 29, 24
Guggenheim Buy Feb 29, 24
Citigroup Buy Dec 4, 23
Citigroup Neutral Jul 28, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Protopapas Anna Director Director Jan 13 Sell 2.71 29,399 79,671 125,153 01/17/24
Protopapas Anna Director Director Jan 13 Option 0 86,958 154,552 01/17/24
MISRA TUSHAR SVP, Chief Manuf. Of.. SVP, Chief Manuf. Officer Jan 13 Sell 2.71 3,357 9,097 17,966 01/17/24
MISRA TUSHAR SVP, Chief Manuf. Of.. SVP, Chief Manuf. Officer Jan 13 Option 0 8,541 21,323 01/17/24
Mandelia Ashish VP, Chief Accounting.. VP, Chief Accounting Officer Jan 13 Sell 2.71 5,025 13,618 23,328 01/17/24
Mandelia Ashish VP, Chief Accounting.. VP, Chief Accounting Officer Jan 13 Option 0 12,780 28,353 01/17/24
Lowinger Timothy B SVP, Chief Sci.&Tech.. SVP, Chief Sci.&Tech. Officer Jan 13 Sell 2.71 10,409 28,208 199,329 01/17/24
Lowinger Timothy B SVP, Chief Sci.&Tech.. SVP, Chief Sci.&Tech. Officer Jan 13 Option 0 29,375 209,738 01/17/24
Carvajal Alejandra SVP, Chief Legal Off.. SVP, Chief Legal Officer Jan 13 Sell 2.71 4,381 11,873 27,403 01/17/24
Carvajal Alejandra SVP, Chief Legal Off.. SVP, Chief Legal Officer Jan 13 Option 0 11,458 31,784 01/17/24
DeSchuytner Brian SVP, COO & CFO SVP, COO & CFO Jan 13 Sell 2.71 9,327 25,276 54,511 01/17/24
DeSchuytner Brian SVP, COO & CFO SVP, COO & CFO Jan 13 Option 0 26,458 63,838 01/17/24
Bala Mohan SVP, Chief Developme.. SVP, Chief Development Officer Jan 13 Sell 2.71 3,431 9,298 14,052 01/17/24
Bala Mohan SVP, Chief Developme.. SVP, Chief Development Officer Jan 13 Option 0 8,750 17,483 01/17/24
Carvajal Alejandra SVP, Chief Legal Off.. SVP, Chief Legal Officer Apr 26 Sell 3.89 3,944 15,342 20,326 04/28/23
Carvajal Alejandra SVP, Chief Legal Off.. SVP, Chief Legal Officer Apr 26 Option 0 13,250 24,270 04/28/23
Yang Arvin SVP, Chief Medical O.. SVP, Chief Medical Officer Jan 13 Sell 5.74 2,209 12,680 30,821 01/18/23
Yang Arvin SVP, Chief Medical O.. SVP, Chief Medical Officer Jan 13 Option 0 7,084 33,030 01/18/23
Protopapas Anna President & CEO President & CEO Jan 13 Sell 5.74 17,346 99,566 48,733 01/18/23
Protopapas Anna President & CEO President & CEO Jan 13 Option 0 55,708 66,079 01/18/23
Mandelia Ashish VP, Controller VP, Controller Jan 13 Sell 5.74 3,575 20,520 13,619 01/18/23
Mandelia Ashish VP, Controller VP, Controller Jan 13 Option 0 10,136 17,194 01/18/23
MISRA TUSHAR SVP, CMO SVP, CMO Jan 13 Sell 5.74 458 2,629 5,930 01/18/23
MISRA TUSHAR SVP, CMO SVP, CMO Jan 13 Option 0 1,459 6,388 01/18/23
Lowinger Timothy B SVP, Chief Sci.&Tech.. SVP, Chief Sci.&Tech. Off. Jan 13 Sell 5.74 6,233 35,777 180,363 01/18/23
Lowinger Timothy B SVP, Chief Sci.&Tech.. SVP, Chief Sci.&Tech. Off. Jan 13 Option 0 20,001 186,596 01/18/23
DeSchuytner Brian SVP, Chief Financial.. SVP, Chief Financial Officer Jan 13 Sell 5.74 5,131 29,452 32,781 01/18/23
DeSchuytner Brian SVP, Chief Financial.. SVP, Chief Financial Officer Jan 13 Option 0 16,458 37,912 01/18/23
Carvajal Alejandra SVP, Chief Legal Off.. SVP, Chief Legal Officer Jan 13 Sell 5.74 782 4,489 11,020 01/18/23
Carvajal Alejandra SVP, Chief Legal Off.. SVP, Chief Legal Officer Jan 13 Option 0 2,500 11,802 01/18/23
Hack Andrew A. F. Director Director May 31 Buy 3.24 95,519 309,482 8,663,673 06/02/22
Hack Andrew A. F. Director Director May 24 Buy 3.22 265,155 853,799 8,568,154 05/26/22
Hack Andrew A. F. Director Director May 19 Buy 3.43 215,599 739,505 8,302,999 05/23/22
Hack Andrew A. F. Director Director May 16 Buy 3.21 350,000 1,123,500 8,087,400 05/18/22
Carvajal Alejandra Chief Legal Officer Chief Legal Officer Apr 26 Option 0 13,250 13,250 04/28/22
Carvajal Alejandra Chief Legal Officer Chief Legal Officer Apr 26 Sell 3.69 3,948 14,568 9,302 04/28/22
Hack Andrew A. F. Director Director Apr 13 Buy 4.05 617,284 2,500,000 7,737,400 04/14/22
Hack Andrew A. F. Director Director Apr 12 Buy 4.1798 598,086 2,499,880 7,120,116 04/13/22
Hack Andrew A. F. Director Director Feb 07 Buy 4.42 1,136,363 5,022,724 6,522,030 02/08/22
Lowinger Timothy B Chief Science & Tech.. Chief Science & Tech Off. Jan 14 Sell 5.92 4,741 28,067 131,234 01/19/22
Mandelia Ashish VP, Controller VP, Controller Jan 14 Sell 5.92 1,982 11,733 3,371 01/19/22
Lowinger Timothy B Chief Science & Tech.. Chief Science & Tech. Officer Mar 24 Option 4.84 8,203 39,703 33,671 03/24/21
Lowinger Timothy B Chief Science & Tech.. Chief Science & Tech. Officer Mar 24 Sell 17.5 8,203 143,552 31,444 03/24/21
Lowinger Timothy B Chief Science & Tech.. Chief Science & Tech. Officer Feb 24 Option 4.84 8,203 39,703 33,671 02/24/21
Lowinger Timothy B Chief Science & Tech.. Chief Science & Tech. Officer Feb 24 Sell 20.01 8,203 164,142 31,444 02/24/21
Mandelia Ashish VP, Controller VP, Controller Jan 20 Sell 21.28 545 11,598 01/20/21
Lowinger Timothy B Chief Science, Tech... Chief Science, Tech. Officer Sep 23 Option 4.84 8,203 39,703 16,865 09/23/20
Jack Eva M. Chief Bus. Officer,.. Chief Bus. Officer, Tres, Sec. Sep 16 Option 1.53 35,248 53,929 35,248 09/16/20
Jack Eva M. Chief Bus. Officer,.. Chief Bus. Officer, Tres, Sec. Sep 16 Sell 22 35,248 775,456 09/16/20